Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori Dodd

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Biostatistics (Oxford, England)|September 24, 2020
Immune correlates analysis using vaccinees from test negative designsDean A Follmann, Lori Dodd
Clinical Trials (London, England)|November 27, 2010
Analysis of progression-free survival data using a discrete time survival model that incorporates measurements with and without diagnostic errorSally Hunsberger, Paul S Albert, Lori Dodd
Annals of Internal Medicine|May 17, 2021
How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19Michael A Proschan, Dean Follmann, Lori Dodd
The Oncologist|May 22, 2010
Blinded independent central review of the progression-free survival endpointOhad Amit, Will Bushnell, Lori Dodd, et al.
Plos Medicine|December 11, 2019
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trialsAndrew Vernon, Katherine Fielding, Rada Savic, et al.
Journal of Proteome Research|July 24, 2009
Profiling human serum antibodies with a carbohydrate antigen microarrayOyindasola Oyelaran, Lisa M McShane, Lori Dodd, et al.
The Journal of Infectious Diseases|November 2, 2013
No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based studyNicolas Wentzensen, Martha Nason, Mark Schiffman, et al.
The Journal of Infectious Diseases|July 23, 2018
The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus InfectionRichard T Davey, Lori Dodd, Michael Proschan, et al.
AJR. American Journal of Roentgenology|June 27, 2012
Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosisPatrick Georgoff, David Thomasson, Adeline Louie, et al.
Journal of Neuroinflammation|July 16, 2018
Brain <sup>18</sup>F-FDG PET of SIV-infected macaques after treatment interruption or initiationWilliam Schreiber-Stainthorp, Sanhita Sinharay, Sharat Srinivasula, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biostatistics (Oxford, England)|September 24, 2020
Immune correlates analysis using vaccinees from test negative designsDean A Follmann, Lori Dodd
Clinical Trials (London, England)|November 27, 2010
Analysis of progression-free survival data using a discrete time survival model that incorporates measurements with and without diagnostic errorSally Hunsberger, Paul S Albert, Lori Dodd
Annals of Internal Medicine|May 17, 2021
How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19Michael A Proschan, Dean Follmann, Lori Dodd
The Oncologist|May 22, 2010
Blinded independent central review of the progression-free survival endpointOhad Amit, Will Bushnell, Lori Dodd, et al.
Plos Medicine|December 11, 2019
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trialsAndrew Vernon, Katherine Fielding, Rada Savic, et al.
Journal of Proteome Research|July 24, 2009
Profiling human serum antibodies with a carbohydrate antigen microarrayOyindasola Oyelaran, Lisa M McShane, Lori Dodd, et al.
The Journal of Infectious Diseases|November 2, 2013
No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based studyNicolas Wentzensen, Martha Nason, Mark Schiffman, et al.
The Journal of Infectious Diseases|July 23, 2018
The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus InfectionRichard T Davey, Lori Dodd, Michael Proschan, et al.
AJR. American Journal of Roentgenology|June 27, 2012
Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosisPatrick Georgoff, David Thomasson, Adeline Louie, et al.
Journal of Neuroinflammation|July 16, 2018
Brain <sup>18</sup>F-FDG PET of SIV-infected macaques after treatment interruption or initiationWilliam Schreiber-Stainthorp, Sanhita Sinharay, Sharat Srinivasula, et al.
Pageof 2